Integrating Assessment of Sarcopenia into Decision-making for Allogeneic Hematopoietic Cell Transplantation: Ready for Prime Time?
- PMID: 31220297
- PMCID: PMC6695298
- DOI: 10.1093/jnci/djy233
Integrating Assessment of Sarcopenia into Decision-making for Allogeneic Hematopoietic Cell Transplantation: Ready for Prime Time?
Comment on
-
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.J Natl Cancer Inst. 2019 Aug 1;111(8):837-844. doi: 10.1093/jnci/djy231. J Natl Cancer Inst. 2019. PMID: 30951603 Free PMC article.
References
-
- Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;6110:1059–1064. - PubMed
-
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. [published online ahead of print Oct 12, 2018]. Age Ageing. 2018; doi: 10.1093/ageing/afy169.
